BlueWeave's Blog

Acne!!! A vaccine for pimples may soon be on the anvil

Published Date | 2018 September 12

United States: Are you suffering from acne? Be happy, a potential vaccine is on its way which will target bacterial toxins, as per researchers. Instead of pervading pathogens, a recent vaccine is arriving in the market who will be the first to target the bacteria which are already present in the human skin. The researchers manifested that antibodies to a toxin that is secreted from bacteria in acne vulgaris can lower amalgamation in human acne abrasion. “Once validated by a large-scale clinical trial, the potential impact of our findings is huge for the hundreds of millions of individuals suffering from acne vulgaris,” explained lead investigator Chun-Ming Huang, from the University of California-San Diego, US. An acne vaccination could evade potential injurious effects of systemic or tropical antibiotics and retinoid which are the present treatment options available. It also revealed that Christie-Atkins-Munch-Peterson (CAMP) factor, is a toxin that is  secreted from Propionibacterium acnes (P. acnes) bacteria, can cause inflammatory reactions. In the recent study which was published in Investigative Dermatology Journal explains that, the group explored in ex vivo and mice in the human skin cells even if they could forbid the inflammation caused by employing antibodies to neutralize the viral factor. The journal also states that, the application of monoclonal antibodies to CAMP 2 factor though reduces the inflammatory reactions. According to BlueWeave Consulting, People are conscious towards their skin and its related problems and will always opt for the treatments which will make the skin problem free. the future studies will keep these factors in mind and will focus on inventing a non-toxic chemical or will target the vaccine formulation for its human application. According to recently published report by BlueWeave Consulting on Global Anti-Aging Market Size, Share, Development, Growth and Demand Forecast to 2025” where we talked about the anti-acne treatment market and  as per our research findings, we stated that North America anti-aging market for anti-adult acne is expected to contribute over 41.1% towards the global market revenue in 2018. The factors such as increase in prevalent cases of acne and easy availability of anti-adult acne products drive the growth of the regional market. Acne is one such problem that people wants to get rid of it. And now as the new vaccine for the anti-acne treatment is round the corner, therefore, the industry will have a significant growth in the upcoming years.